Learn more about this study and novel #vaccine technologies at our webinar. Hoffmann Lab Caltech, Anna Blakney University of British Columbia, Aliasger Salem University of Iowa, and Jinjun Shi Harvard Medical School will discuss recent breakthroughs in vaccine development. 📅Feb 27 @ 1:30PM ET Register: ow.ly/9GSe50MCx7J

As #mRNA research and #nanotechnology advance, what will future #vaccines be like? Hear Hoffmann Lab Caltech, Anna Blakney University of British Columbia, Aliasger Salem University of Iowa, and Jinjun Shi Harvard Medical School discuss the latest vaccine developments. 📆 February 27 @ 1:30PM EST ow.ly/59ho50MShj0

Dr Kim Dam is representing the Bjorkman Lab and Hoffmann Lab at the CAVD Norman L. Letvin Early Career Investigator Conference in South Africa! We couldn’t ask for a better scientist to showcase our work to the world ☺️

Researchers are advancing #vaccine technologies to prevent the next pandemic and #cancer. Learn how Hoffmann Lab Caltech, Anna Blakney University of British Columbia, Aliasger Salem University of Iowa, and Jinjun Shi Harvard Medical School develop novel vaccine platforms. 📆 Mon, Feb 27 @ 1:30PM EST ow.ly/YJpI50MCwQJ

Don't miss our latest webinar happening Monday! Join Hoffmann Lab Caltech, Anna Blakney University of British Columbia, Aliasger Salem University of Iowa, and Jinjun Shi Harvard Medical School as they discuss rapidly evolving vaccine technology. 📆 Monday, February 27 @ 1:30 PM EST Claim your spot now: ow.ly/M75y50N1sBF

A novel vaccine strategy that combines the flexibility and speed of mRNA and superior nanoparticle immunogenicity (VLPs-virus like particles) cell.com/cell/fulltext/… Seth Zost Robert Carnahan cell.com/cell/fulltext/… The Bjorkman Lab Caltech

Sending thanks and deep appreciation to our friends Marta and Mark in the The Bjorkman Lab! We are blessed to have such dedicated, incredible individuals to work alongside 😊

Excited to introduce our new postdoc Sameh Ali, PhD!

Learn more on how the EABR technology is revolutionizing vaccination efforts: caltech.edu/about/news/new… Kudos to our team Caltech and collaborators! The Bjorkman Lab Zhi Yang Check out the Cell paper for more details. 📚 #Vaccines #Innovation

The antibodies produced by the new vaccine were effective against the original strain of SARS-CoV-2, the delta variant, and omicron variants. caltech.edu/about/news/new…

🔬 Exciting findings in our latest publication out in @nature! This work delves into the dynamic world of HIV-1 envelope structures, revealing distinct conformational changes during host receptor (CD4) engagement. 🧬💡

Caltech researchers, led by Professor Pamela Björkman, have imaged an elusive HIV protein structure at the atomic scale, offering unprecedented insights into the HIV infection process. #WorldAIDSDay2023 caltech.edu/about/news/ima…

Thanks for inviting the Hoffmann lab to the party, The Bjorkman Lab!

Check out Dr. Hoffmann's interview with Vaccine Insights! Learn about our lab's innovative work with hybrid mRNA vaccines is revolutionizing vaccine development. 🦠 insights.bio/vaccine-insigh…

The promising pan-sarbecovirus vaccine from Caltech sciencedirect.com/science/articl… Cell

The Hoffmann lab is thrilled to announce that we are now a part of the Gladstone Institutes! We are so grateful for the opportunity to continue our research among such talented and influential scientists.

Gladstone’s Magnus Hoffmann (Hoffmann Lab) seeks to advance a new generation of more effective vaccines, improved drug delivery methods, and a greater overall understanding of vaccine-induced immune responses. bit.ly/4hDlmzm

Way to go, The Bjorkman Lab! Well deserved!